Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Total revenue from sales of goods and services
3Y CAGR
-0.3%/yr
vs +79.5%/yr prior
5Y CAGR
+79.9%/yr
Recent deceleration
Acceleration
-79.8pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
18.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $14.56M | +53.2% |
| 2024 | $9.50M | +6.2% |
| 2023 | $8.95M | -39.2% |
| 2022 | $14.70M | +277.4% |
| 2021 | $3.90M | +404.0% |
| 2020 | $773000.00 | -47.7% |
| 2019 | $1.48M | +4.4% |
| 2018 | $1.42M | -21.0% |
| 2017 | $1.79M | -20.4% |
| 2016 | $2.25M | - |